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Background: Psychological stressors may cause affective disorders, such as depression and anxiety, by altering
expressions of corticotropin releasing factor (CRF), serotonin (5-HT), and tyrosine hydroxylase (TH) in the brain. This
study investigated the effects of essential oil from Asarum heterotropoides (EOAH) on depression-like behaviors and
brain expressions of CRF, 5-HT, and TH in mice challenged with stress.
Methods: Male ICR mice received fragrance inhalation of EOAH (0.25, 0.5, 1.0, and 2.0 g) for 3 h in the special cage
capped with a filter paper before start of the forced swimming test (FST) and tail suspension test (TST). The
duration of immobility was measured for the determination of depression-like behavior in the FST and TST. The
selective serotonin reuptake inhibitor fluoxetine as positive control was administered at a dose of 15 mg/kg (i.p.)
30 min before start of behavioral testing. Immunoreactivities of CRF, 5-HT, and TH in the brain were also measured
using separate groups of mice subjected to the FST.
Results: EOAH at higher doses (1.0 and 2.0 g) reduced immobility time in the FST and TST. In addition, EOAH at a
dose of 1.0 g significantly reduced the expected increases in the expression of CRF positive neurons in the
paraventricular nucleus and the expression of TH positive neurons in the locus coeruleus, and the expected
decreases of the 5-HT positive neurons in the dorsal raphe nucleus.
Conclusion: These results provide strong evidence that EOAH effectively inhibits depression-like behavioral responses,
brain CRF and TH expression increases, and brain 5-HT expression decreases in mice challenged with stress.
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Physical and psychological stressors are thought to cause
affective disorders including depression and anxiety [1,2].
The neurobiological substrate for depression-like behaviors
induced by stress is believed to involve corticotropinergic
neurons in the paraventricular nucleus, noradrenergic neu-
rons in the locus coeruleus, and serotonergic system in
the dorsal raphe nucleus [3,4]. The involvement of these
substrates is supported by the report that selective serotonin* Correspondence: chyang@dhu.ac.kr
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unless otherwise stated.reuptake inhibitor (SSRI), serotonin-norepinephrine re-
uptake inhibitor (SNRI), norepinephrine-dopamine reuptake
inhibitor, and inhibitor of hypothalamic-pituitary-adrenal
(HPA) axis are used for the treatment of depression [5].
However, the clinical satisfaction is still under debating
due to unwanted side effects and genetic variation. There-
fore, the alternative medication is necessary to provide ef-
fective approaches for reducing the depression.
Studies in laboratory animals and humans have dem-
onstrated that inhalation of essential oils can produce
antidepressant and anxiolytic effects exposed to stress by
modulating the central nervous system. For examples,
inhalation of lemon oil reduced anxiogenic and depres-
sant effects in an elevated plus-maze test and a forcedis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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dopaminergic pathways in mice brain [6]. In addition, lav-
ender oil inhalation decreased anxiety and depression-like
behaviors of rats in an elevated plus-maze test and a FST
[7]. Lavender oil inhalation is also effective in reducing
stress-related symptoms in nurses [8].
Asarum heterotropoides Fr. Mandshuricum has been
shown to be effective for reducing anxiety and for the relief
of pain [9,10]. Furthermore, biological and pharmacological
studies have demonstrated that Asarum heterotropoides
can produce wide spectrums of action including anti-
inflammatory effect [11,12] and anti-allergic [13] and anti-
oxidant activity [14].
The present study was carried out to investigate the ef-
fects of inhalation of essential oil from Asarum heteropoides
(EOAH) on depression–like behaviors in the FST and tail
suspension test (TST). A role for brain corticotropin releas-
ing factor (CRF), serotonin (5-HT), and tyrosine hydroxy-
lase (TH) expression in EOAH effects is also explored.
Methods
Animals
Male mice of ICR strain (Orient Inc., South Korea) at
5 weeks after the birth were housed under a controlled
temperature (23 ± 2°C) and humidity (50 ± 10%) with a
12 h light–dark cycle (lights on at 8:00 h). Food and
water were made available ad libitum for the study. All
animal experiments were carried out in accordance with
the animal care guidelines of the National Institute of
Health (NIH) and approved by the Institutional Animal
Care and Use Committee of Daegu Hanny University.
Preparation of EOAH and chemical analysis
The dried and chipped roots of Asarum heterotropoides
(1.2 kg) were purchased from Daegu Yangnyeongsi (a trad-
itional herb market) in Daegu, South Korea. The pulver-
ized Asarum heterotropoides were used to extract essential
oil at the room temperature with n-hexane (5 L x 2) for
24 h. The extracts (EOAH) were filtered and evaporated
in the vacuum at 40°C to remove n-hexane. The final
concentration of essential oil was 22.5 g. The specimen of
this plant material (RCBROM-AEM2012) is deposited
at the Research Center for Biomedical Resources of
Oriental Medicine, Daegu Haany University. EOAH was
analyzed for the determination of chemical composition
using GC-MS (Agilent Technologies 7890A/5975C insert
XL Mass Selective detector) with injection volume 1 μl
(Column: DB-5MS; 250 μm i.d.; 30 m length; 0.25 μm film
thickness; split ratio 1:50. Carrier: Helium. Injector 250°C,
Detector 280°C, Column 70°C, 1 min; 4°C/min to 300°C
for 20 min). The identification of EOAH was carried
out by comparing their relative retention time and mass
spectra to those generated by chromatographic analysis of
standards and W9N08.L library and literature.Inhalation of EOAH
To evaluate the effects of EOAH on depression-like be-
haviors, the mice were randomly divided into the follow-
ing 5 groups: Control (n = 5); EOAH 0.25 g (n = 5); EOAH
0.5 g (n = 5); EOAH 1.0 g (n = 5); EOAH 2.0 g (n = 5).
Mice weighing between 25 and 30 g at the start of the ex-
periment were used. The mice were pretreated with inhal-
ation of EOAH (0.25, 0.5, 1.0, and 2.0 g) or saline (control
group). The inhalation dose of essential oil was chosen
based on previous studies [15,16]. To induce saturation of
the fragrance by EOAH in the transparent special cage
(W 26 X L 22 X H 20 cm), EOAH put 30 min before
the individual inhalation of EOAH for 3 h in the special
cage under standardized condition (room temperature:
23 ± 2°C, relative humidity: 50 ± 10%). The special cage
was capped with a filter paper, which allowed minimum
breathing air to pass. In order to vaporize essential oil effi-
ciently, EOAH was put in uncapped eppendorf tube set on
the upper side of an inhalation cage. After inhalation of
EOAH, no mice have shown abnormal behaviors includ-
ing enhanced locomotion, loss of body postures, sweats,
head turns and vocalization. The selective serotonin re-
uptake inhibitor fluoxetine (Sigma-Aldrich, St. Louis, MO,
U.S.A.) was dissolved in saline. Mice were treated with
15 mg/kg of fluoxetine (n = 7) as positive control or saline
(control group, n = 7) by intraperitoneal injection 30 min
before the start of behavioral testing. An injection volume
was 0.3 ml/30 g body weight.
FST and TST
Following inhalation of EOAH, the mice were subjected to
the FST and TST, respectively. The duration of immobility
induced by forced swimming was measured as described
previously with slight modification [17]. The mice were in-
dividually exposed to forced swimming in a transparent
acrylic cylinder (25 cm in height and 10 cm in diameter)
containing 20 cm height of water at 23°C. The immobility
was defined as floating motionless in the water [18]. The
duration of immobility was measured during the last 4 min
of total 6 min test using a video based Ethovision System
(Noldus, Wageningen, Netherlands). TST was carried out
according to the method described previously with a slight
modification [19]. In brief, the mice were individually hung
5 cm above the floor in clear black acrylic boxes (30 cm ×
30 cm × 50 cm) by tail attachment using an adhesive tape
to a hook. The mice were individually allowed to hang for
6 min and the duration of immobility was recorded during
the last 4 min of total 6 min test. The immobility was de-
fined as absence of body movements [19].
Immunohistochemistry
The expressions of 5-HT, TH, and CRF were measured
using different groups of mice. Mice were divided 4
groups: Normal (n = 8); Control (n = 9); EOAH 0.5 g
Park et al. BMC Complementary and Alternative Medicine  (2015) 15:43 Page 3 of 8(n = 9); EOAH 1.0 g (n = 9). At the end of the FST, mice
were sacrificed and brains were prepared to measure the
expressions of 5-HT, TH, and CRF, respectively. Mice in
normal group were not allowed to have the FST. Immu-
nohistological study began with transcardial perfusion of
heparinized phosphate-buffered saline (PBS; pH 7.4) for
30 s followed by perfusion of 4% paraformaldehyde in
0.1 M phosphate buffered saline (pH 7.4) for 10–15 min.
Brains were removed and allowed to stand in the same
fixative by overnight, followed by cryoprotected in 30%
sucrose solution in PBS. The individual brain was em-
bedded in OCT compound and serially sectioned on a
cryostat (Leica, Nussloch, Germany) at 30 μm thickness
by the coronal plane, and then collected in PBS using
free floating methods. The individual primary antibody
includes anti-5HT (rabbit monoclonal, 1:200; Abcam,
Cambridge, U.S.A.), anti-CRF (rabbit monoclonal, 1:200;
Abcam, Cambridge, U.S.A.), and anti-TH (rabbit mono-
clonal, 1:2000; Abcam, Cambridge, U.S.A.) was incubated
in a cocktail solution (0.3% PBST, 2% blocking serum
and 0.001% keyhole limpet hemocyanin) for 72 h at
4°C, respectively. After three time rinses in PBS, the sec-
tions were placed in Vectastain Elite ABC reagent (Vector
laboratories, Burlingame, CA, U.S.A.) for 2 h at room
temperature. Following a further rinsing in PBS, the tissue
was developed using diaminobenzadine (Sigma-Aldrich,
St. Louis, MO, U.S.A.) as the chromogen. The images of
5-HT-, CRF-, and TH-immunoreactive neurons were cap-
tured using a DP2-BSW imaging system (Olympus, CA,
USA) and measured as described by others [20]. In brief,
the grid was placed on the target area in the brain and the
number of cells was counted at 100 x magnification using
a microscope rectangle grid. The five sections were col-
lected at the levels of the dorsal raphe nucleus, the para-
ventricular nucleus and the locus coeruleus in each brain
for 5-HT, CRF and TH immunoreaction. The cells were
counted and averaged from five sections.Statistical analysis
Statistical analysis of data was carried out using SPSS 15.0
for Windows. Depression-like behaviors and brain 5-HT-,
TH-, and CRF-immunoreactivity were statistically ana-
lyzed by one-way ANOVA and post-hoc Newman-Keuls
test to compare the experimental and control groups. An
unpaired t-test was performed to determine statistical sig-
nificance for fluoxetine versus saline comparison. The sig-
nificance level was set at p < 0.05, p < 0.01, and p < 0.001.Results
Major compounds of EOAH
The total 78 peaks were detected in EOAH. The main
compounds in analyzed samples were methyl eugenol
(22.58%), pentadecane (6.78%), 2,3,5-trimethoxytoluene(5.54%), 4-(chloromethyl) cyclohexene (3.36%), myristi-
cine (3.27%), sesamin (3.24%), and kakoul (2.63%).
The effect of EOAH on the depression-like behaviors
Inhalation of EOAH at higher doses (1.0 and 2.0 g) signifi-
cantly reduced immobility time in the FST (Figure 1A). A
one-way ANOVA identified a significant main effect
(F4,20 = 3.19, p < 0.05). Post hoc tests revealed that mice
receiving saline (control) had significantly greater immo-
bility time than those treated with EOAH during the FST
(p < 0.05). When mice were exposed to the TST, inhalation
of EOAH (0.25, 0.5, 1.0, and 2.0 g) significantly decreased
immobility time (Figure 1C). Interestingly, an antidepres-
sant effect of EOAH at lower doses was more apparent in
the TST. A one-way ANOVA identified a significant main
effect (F4,20 = 3.63, p < 0.05). Post hoc tests revealed that mice
receiving saline had significantly greater immobility time
than those treated with EOAH during the TST (p < 0.05).
Similarly, administration of fluoxetine markedly reduced
immobility time at both the FST and TST compared to sa-
line group (p < 0.01, p < 0.001, respectively, Figure 1B and
D). This provides additional evidence that EOAH effectively
reduces depression-like behaviors. In our study, EOAH at
higher doses significantly suppressed depression-like behav-
iors in the FST. Thus, EOAH at a dose of 1.0 g was exposed
to mice subjected to the FST in order to identify EOAH
effects on brain levels of 5-HT, CRF, and TH.
5-HT-immunoreactive neurons in the dorsal raphe nucleus
Changes in the expression of 5-HT-immunoreactive
neurons were evaluated in mice exposed to the FST fol-
lowing inhalation of EOAH (Figure 2A-D). As shown in
Figure 2E, a much larger decrease in the mean number
of 5-HT-immunoreactive neurons in the dorsal raphe
nucleus was produced in mice exposed to the FST
compared with normal mice. While the FST markedly
decreased the expression of 5-HT in the dorsal raphe
nucleus in mice receiving inhalation of saline (p < 0.01),
inhalation of EOAH (1.0 g) increased 5-HT expression
in the dorsal raphe nucleus. A one-way ANOVA analysis
revealed a significant main effect of EOAH inhalation
(F3,31 = 8.339, p < 0.001). Post-hoc comparisons indi-
cated that there was a significant enhancement in the
5-HT activity in the dorsal raphe nucleus of the 1.0 g
EOAH group compared with the control group (p < 0.01).
Group 0.5 g EOAH mice tended to have greater 5-HT ac-
tivity in the dorsal raphe nucleus than the control group,
but these differences were not statistically significant.
CRF-immunoreactive neurons in the paraventricular nucleus
The expression of CRF in the paraventricular nucleus
was shown after inhalation of EOAH (Figure 3A-D).
Control mice exposed to the FST had significantly higher
mean number of CRF-immunoreactive neurons than
Figure 1 Effects of inhalation of EOAH on the FST and TST in mice. The mice were pretreated with inhalation of EOAH (0.25, 0.5, 1.0, and
2.0 g; EOAH groups) or saline (control group) prior to FST or TST. The graph (A and C) represents the immobility time during a 4 min period in
all groups (n = 5 per each group). Data were analyzed by one-way ANOVA and post-hoc Newman-Keuls test. For comparative purpose, mice were
administered with fluoxetine or saline. The graph (B and D) represents the immobility time during a 4 min period in all groups (n = 7 per each
group). Data were analyzed by t-test. Each value represents the mean ± S.E.M. *p < 0.05 compared to the control group.
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creased the expression of CRF in the paraventricular nu-
cleus in mice receiving inhalation of saline (p < 0.001),
there was an increase in 5-HT expression in those receiv-
ing inhalation of EOAH (0.5 and 1.0 g). A one-way
ANOVA revealed a significant main effect of the treat-
ment on the expression of CRF-immunoreactive neurons
in the paraventricular nucleus (F3,31 = 11.060, p < 0.001).
Post hoc tests indicated that inhalation of EOAH (0.5 and
1.0 g) induced marked increases in the expression of
CRF-immunoreactive neurons in the paraventricular nu-
cleus compared with saline-treated mice (p < 0.05, p < 0.001,
Figure 3E).
TH-immunoreactive neurons in the locus coeruleus
The expression of TH in the paraventricular nucleus
was shown after inhalation of EOAH (Figure 4A-D).
Similar to the CRF data, mice exposed to the FST
showed a significant difference in the mean number of
TH-immunoreactive neurons in the locus coeruleus
from normal group (p < 0.001, Figure 4E). However,
inhalation of EOAH significantly reduced the expressionof TH in the locus coeruleus compared to saline inhalation.
A one-way ANOVA revealed a significant main effect of
the treatment on the expression of TH-immunoreactive
neurons in the LC (F3,31 = 36.040, p < 0.001). Post hoc tests
indicated that inhalation of EOAH (0.5 and 1.0 g) induced
marked increases in the expression of TH-immunoreactive
neurons in the locus coeruleus compared with treatment of
saline (p < 0.001, Figure 4E).
Discussion
The present results demonstrated that the inhalation of
EOAH effectively attenuated depression-like behavior, in-
creases in brain expressions of CRF and TH, a decrease in
brain expressions of 5-HT in response to 6 min of forced
swimming or immobilization stress. Behavioral responses
to the FST and TST are consistent with previous findings
[3,4]. The FST and TST are useful tests for screening
antidepressant drugs and exploring their mechanisms of
action, because of its good reliability and predictive valid-
ity [21]. The FST and TST commonly trigger psychological
despairs with no escapable hope from immobilization
by learning that escape from the current situation is
Figure 2 Effect of inhalation of EOAH on 5-HT expression in the
dorsal raphe nucleus in mice subjected to the FST. Photographs
represent the distribution of 5-HT-immunoreactive neurons in the
dorsal raphe nucleus of normal (A, n = 8), control (B, n = 9), EOAH
0.5 g (C, n = 9) and EOAH 1.0 g (D, n = 9) groups. The number of
5-HT immunostained neurons among the groups (E) was analyzed
by one-way ANOVA post-hoc Newman-Keuls test. Each value
represents the mean ± S.E.M. ##p < 0.01 compared to the normal
group, **p < 0.01 compared to the control group. Sections were
cut coronally at 30 μm and the scale bar represents 200 μm.
Arrowheads indicate 5-HT immunopositive neurons.
Figure 3 Effect of inhalation of EOAH on CRF expression in
the paraventricular nucleus in mice subjected to the FST.
Photographs represent the distribution of CRF-immunoreactive cells
in the paraventricular nucleus of normal (A, n = 8), control (B, n = 9),
EOAH 0.5 g (C, n = 9) and EOAH 1.0 g (D, n = 9) groups. The number
of the CRF immunostained neurons among the groups (E) was
analyzed by one-way ANOVA post-hoc Newman-Keuls test. Each
value represents the mean ± S.E.M. ###p < 0.001 compared to the
normal group. *p < 0.05 and **p < 0.01 compared to the control
group. Sections were cut coronally at 30 μm and the scale bar
represents 200 μm. Arrowheads indicate CRF immunopositive neurons.
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and consequently develop depression status [17].
Pharmacologically, a variety of anti-depressants and
related-compounds with potential anti-depressant activ-
ity reduce the duration of immobility in the FST and
TST [22,23]. Therefore, the reduction of immobility is
the important factor to develop the pharmacological ap-
proaches to the treatment of depression-like behaviors
in experimental designs. Our results suggest that inhal-
ation of EOAH reduces depression-like behaviors in the
FST and TST. However, our results showed that lower
doses of EOAH did not produce a significant effect on
depression-like behaviors in the FST. This differs with
effects of EOAH at lower doses in the TST as demon-
strated by a significant decrease in depression-like be-
haviors. Such inconsistencies may be at least in part
related to differences in response to EOAH between theFST and TST. In support of this, one study has shown
that TST is more responsive to neurochemical changes
than the FST [24]. The present results are similar to
others who demonstrated that pure fragrance of aroma
oil and essential oil from plants decreased depression-
like behaviors in the FST and TST [25,26]. Further sup-
port for a role of EOAH is the observation that systemic
administration of methyl eugenol, which is known to be
one of volatile components of Asarum heterotropoides
[27], produced anti-anxiety and anti-depression effects
in the FST [28].
Depression-like behaviors induced by stressors have
been linked to endogenous systems of CRF and mono-
amines including 5-HT and NE [29,30]. Pharmacological
studies have shown that CRF1 receptor antagonist,
5-HT1 receptor agonist, and adrenoreceptor antagonist
can decrease depression-like behaviors, indicating that
Figure 4 Effect of inhalation of EOAH on TH expression in
the locus coeruleus in mice subjected to the FST. Photographs
represent the distribution of TH-immunoreactive cells in the locus
coerleus of normal (A, n = 8), control (B, n = 9), EOAH 0.5 g (C, n = 9)
and EOAH 1.0 g (D, n= 9) groups. The number of the TH-immunostained
neurons among the groups (E) was analyzed by one-way ANOVA
post-hoc Newman-Keuls test. Each value represents the mean ± S.E.M.
###p < 0.001 compared to the normal group, **p < 0.01 compared
to the control group. Sections were cut coronally at 30 μm and
the scale bar represents 200 μm. Arrowheads indicate TH
immunopositive neurons.
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5-HT and NE in the brain contribute to development
of depression [31-34]. Thus, it is not unexpected that
normalization of these systems attenuates depression-
like behaviors [35-37]. In our study, mice subjected to
forced swimming stress showed significant increases in
brain expressions of CRF and NE, and significant de-
creases in brain expression of 5-HT. These results are
consistent with previous findings, suggesting that en-
dogenous systems of CRF, 5-HT, and NE in the brain
plays an important role in modulating depression-like
behaviors. For example, the expression of CRF mRNA
or CRF immunoreactivity in the hypothalamic neurons
is known to be up-regulated by stressor including forced
swimming stress [38,39]. Similarly, CRF 2 mutant mice
showed increased immobility time in forced swimming test
[40]. It is noteworthy that one particular stressor, forced
swimming, was associated with decreases of extracellular5-HT in several brain regions including the dorsal raphe
nucleus, lateral septum, and amygdala [41,42]. Also, sero-
tonin receptor 1A knockout (KO) mice or serotonin trans-
porter KO mice exhibited a decreased immobility time in
the forced swim test [43,44]. In contrast, exposure to
forced swimming considerably enhanced the release of
norepinephrine in the locus coeruleus [45,46]. In addition,
norepinephrine transporter KO mice have been shown to
reduce immobility in the FST and TST [44]. Therefore, it
is highly likely that depression-like behaviors are due to
activation of CRF neurons in the hypothalamus and nor-
adrenergic neurons in the locus coeruleus and suppression
of serotonergic neurons in the dorsal raphe nucleus.
Most importantly, results showed that EOAH at the
dose of 1.0 g significantly reduced the expected increases
in the expression of CRF positive neurons in the
paraventricular nucleus, the expected decreases in the
expression of TH in the locus coeruleus and the 5-HT
positive neurons in the dorsal raphe nucleus in mice
subjected to forced swimming stress. Also, EOAH at
the dose of 1.0 g reduced a significant increase in immo-
bility time in the FST and TST. Based on a role for en-
dogenous systems of CRF, 5-HT, and NE in the brain,
one possible mechanism where EOAH could diminish
depression-like behaviors is by affecting brain levels of
5-HT, CRF, and TH. Recently, it has been proposed a
hypothetical model that might explain how inhalation of
volatile essential oils activates brain areas [33]. In brief,
volatile molecules of essential oil may diffuse into the
systemic circulation through the lung, which inhalation
takes them to. Subsequently, they are transported to
brain areas. In addition, the molecules activate the olfac-
tory system connected to the limbic system via binding
to olfactory receptors. Determination of the specific
mechanisms involved in anti-depressant effects induced
by EOAH will require additional study.Conclusion
In conclusion, our results suggest that the reduced stress
response produced by inhalation of EOAH is most likely
mediated via an activation of serotonergic system and an
inhibition of corticotropinergic and catecholaminergic
system in the brain.
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